Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer

Noah D Peyser1, Kelsey Pendleton2, William E Gooding3

  • 1Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, CA, United States of America, 94143.

Plos One
|November 18, 2016
PubMed
Abstract

Insights

STAT3 activation is common in head and neck cancers but its causes are unclear. Unbiased analysis of TCGA data revealed gene expression changes, not mutations, linked to STAT3 phosphorylation in HNSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Constitutive phosphorylation of Signal Transducer and Activator of Transcription 3 (STAT3) at tyrosine 705 (pSTAT3(Y705)) is prevalent in human cancers, including head and neck squamous cell carcinoma (HNSCC).
  • The underlying genetic and epigenetic alterations driving STAT3 activation in cancer are not fully understood, as STAT3 itself is rarely mutated.
  • The Cancer Genome Atlas (TCGA) provides a comprehensive resource for investigating cancer-related genomic and epigenomic changes.

Purpose of the Study:

  • To identify genomic and epigenomic alterations associated with STAT3 activation in HNSCC using an unbiased approach.
  • To correlate pSTAT3(Y705) protein expression with various molecular data from TCGA, including mutations, mRNA expression, promoter methylation, and copy number alterations.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) dataset, extracting mutation, mRNA expression, promoter methylation, and copy number alteration data.
  • Examined the association between these molecular features and pSTAT3(Y705) protein expression levels.
  • Validated the association between pSTAT3(Y705) and caspase-8 mRNA expression using immunoblot analysis in HNSCC cell lines.

Main Results:

  • A significant association was found between pSTAT3(Y705) expression and the mRNA levels of 1279 genes.
  • The expression of caspase-8 mRNA was confirmed to be associated with pSTAT3(Y705) expression.
  • No significant association was observed between increased pSTAT3(Y705) protein expression and gene mutations, promoter hypermethylation, or copy number alterations.

Conclusions:

  • Unbiased analytical approaches are valuable for uncovering the molecular mechanisms driving oncogenic signaling pathways like STAT3 activation in HNSCC.
  • The study highlights that gene expression changes, rather than direct genetic or epigenetic alterations, may be more closely linked to STAT3 activation in HNSCC.
  • Larger datasets are required to fully elucidate the downstream signaling effects of less frequent genetic alterations potentially influencing STAT3 activation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.9K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K